EUVIMEDEUVIMED felfedezése
Crossref

Surgical Treatment in Very Advanced (T4b) Adenoid Cystic Carcinoma of the Head and Neck

Michael R Papazian iD, Michael Chow, Jamie Oliver, Alex J Gordon, Adam Jacobson, Alec Vaezi, Moses Tam, Babak Givi

Otolaryngology–Head and Neck Surgery · 2023

DOI: 10.1002/ohn.203 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2023. Written by Michael R Papazian and 7 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, NYU Langone Health, New York, New York, USA. Major MEDLINE topics: Carcinoma, Adenoid Cystic, Mouth Neoplasms, Head and Neck Neoplasms, Carcinoma. Cited 7 times so far (Crossref); 20 references.

AbsztraktSubjectsBibliográfiai adatokCiteRelated studies

Abstract (original language)

Objective

To compare treatment outcomes for T4b head and neck adenoid cystic carcinoma (ACC). Study Design Historical cohort study.

Setting

National Cancer Database (NCDB).

Methods

Identified all T4b ACC of head and neck origin diagnosed 2004 to 2019 in the NCDB. Demographics, clinical characteristics, treatment details, and survival were analyzed. Treatment outcomes were analyzed using univariable and multivariable Cox regression.

Results

We identified 606 cases of T4b ACC. Less than half (284, 47.0%) underwent curative‐intent treatment. Among these, most were treated with primary surgery: surgery + radiotherapy (RT) (122, 43.0%) or surgery + chemoradiotherapy (CRT) (42, 14.8%). The positive margin rate was 78.7%, and 90‐day postoperative mortality was zero. Nonsurgical patients were treated with definitive RT (60, 21.1%) or definitive CRT (60, 21.1%). The median follow‐up was 51.5 months. Overall survival was 77.8% at 3 years. Three‐year survival was higher for patients treated with surgery compared to those treated nonsurgically (84% vs 70%; p = .005). Surgical treatment remained associated with higher survival on multivariable analysis (hazard ratio [HR]: 0.47, p = .005). This effect was most pronounced for oral cavity tumors (HR: 0.17, p = .01). Among matched cohorts of surgically treated patients, there was no difference in 3‐year survival between clinical T4a and T4b tumors (83.3% vs 83.0%, p = .99).

Conclusion

Long‐term survival for T4b ACC of the head and neck could be expected. Primary surgical treatments can be performed safely and are associated with longer survival. A carefully selected subset of patients with very advanced ACC might benefit from the consideration of surgical treatments.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Adenoid CysticMouth NeoplasmsHead and Neck NeoplasmsCarcinomaHumansCohort StudiesTreatment OutcomeRetrospective Studies

Author keywords

adenoid cystic carcinomaadvancedstage T4bsurgerysurvival

Authors and institutions

  • Department of Otolaryngology-Head and Neck Surgery, NYU Langone Health, New York, New York, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, New York, USA.
  • Department of Radiation Oncology, NYU Langone Health, New York, New York, USA.
  • Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID profiles: Michael R Papazian

Cite

APA

Papazian, M. R., Chow, M., Oliver, J., Gordon, A. J., Jacobson, A., Vaezi, A., Tam, M., & Givi, B. (2023). Surgical Treatment in Very Advanced (T4b) Adenoid Cystic Carcinoma of the Head and Neck. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.203

Vancouver

Papazian MR, Chow M, Oliver J, Gordon AJ, Jacobson A, Vaezi A, et al. Surgical Treatment in Very Advanced (T4b) Adenoid Cystic Carcinoma of the Head and Neck. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.203

BibTeX
@article{Papazian2023,
  author = {Papazian, Michael R and Chow, Michael and Oliver, Jamie and Gordon, Alex J and Jacobson, Adam and Vaezi, Alec and Tam, Moses and Givi, Babak},
  title = {Surgical Treatment in Very Advanced (T4b) Adenoid Cystic Carcinoma of the Head and Neck},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2023},
  doi = {10.1002/ohn.203}
}
Start for free →